Tags: acquisitionRemove, indiaRemove

M&A
As the year draws to a close, private-equity firm Actis orchestrates the sale of its portfolio company Paras Pharmaceuticals in India to Reckitt Benckiser for $726 million.
By Sameera Anand | 14 December 2010
M&A
China Huaneng Group gains control of a global portfolio of power-generating assets after being declared the winning bidder for GMR's 50% equity interest in independent power ...
By Sameera Anand | 30 November 2010
M&A
HSBC will pay a premium of up to $95 million for Royal Bank of Scotland’s retail and commercial businesses in India.
By Lara Wozniak, Rupert Walker | 5 July 2010
Tag Filters
Polls
What is your outlook on China?


   |   View results
Long-term bullish, I'm buying on the dips
  45%
 
Cautious
  32%
 
Expecting a hard landing
  23%
TOTAL VOTES: 71

 
WEBCASTS
On Demand Webcasts
Magazine
FinanceAsia Magazine
FinanceAsia
May 2012